Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
about
Interleukin-22 Signaling in the Regulation of Intestinal Health and DiseaseThe gastrointestinal tumor microenvironmentREG1B as a predictor of childhood stunting in Bangladesh and Peru.The expression of REG 1A and REG 1B is increased during acute amebic colitis.Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditisIL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signalingIL-22 is related to development of human colon cancer by activation of STAT3.IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Activation of REG family proteins in colitisSignificance of Interleukin-6/STAT Pathway for the Gene Expression of REG Iα, a New Autoantigen in Sjögren's Syndrome Patients, in Salivary Duct Epithelial Cells.HVEM: An unusual TNF receptor family member important for mucosal innate immune responses to microbes.Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.REG gene expression in inflamed and healthy colon mucosa explored by in situ hybridisation.Animal models of IBD: linkage to human disease.Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.Healing of intestinal inflammation by IL-22.IL-22, not simply a Th17 cytokine.Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?Therapeutic opportunities of the IL-22-IL-22R1 system.Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease.Synergistic activations of REG I α and REG I β promoters by IL-6 and Glucocorticoids through JAK/STAT pathway in human pancreatic β cells.IL-22 promotes fibroblast-mediated wound repair in the skin.Up-regulated Reg proteins induced by Interleukin-22 treatment ameliorate acute liver injury in rat model.Interleukin-6/STAT pathway is responsible for the induction of gene expression of REG Iα, a new auto-antigen in Sjögren׳s syndrome patients, in salivary duct epithelial cells.Expression of REG family genes in human inflammatory bowel diseases and its regulation.Clinical importance of IL-22 cascade in IBD.IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression.A novel, dual cytokine-secretion assay for the purification of human Th22 cells that do not co-produce IL-17A.A catch-22: Interleukin-22 and cancer.Molecular characteristics of rhesus macaque interleukin-22: cloning, in vitro expression and biological activities.Involvement of autoimmunity to REG, a regeneration factor, in patients with primary Sjögren's syndrome.Expression of Reg family genes in the gastrointestinal tract of mice treated with indomethacin.ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases
P2860
Q26770224-4E657431-49E9-4621-9F1D-DEAC79D20479Q26827391-8AAA728A-D628-40DC-996A-51E7B4BD83B1Q30413251-11164AE7-3B14-4A6C-BEBD-3FA8065D8D49Q30425298-4AC43E9C-880B-48BD-8054-D6D796AEE374Q34029102-6733657E-0025-4A4E-A202-CA8726630BBBQ34051942-33E0DFDA-5FE2-4C56-946E-756580FB2CA1Q34573878-CF575131-0E91-47BA-A82F-25B989DF8628Q34733135-FD203589-FA4C-4E28-A5FA-8006F9701FEEQ35022269-A5B20528-C612-4A1E-96DB-E894AE1AC48DQ35540664-151F5130-D394-448A-A6A6-4D1A36F291B3Q36060629-CFC8EAC4-F900-4C67-94AD-0DA32CC9C840Q36677090-AA684B3A-062F-4B76-91ED-C384BF7E98F0Q36780412-D6F3A29C-EE1B-405D-8298-128046EC3F80Q36819589-F9999679-4DBA-4B4E-9549-29359F0D0760Q36875132-5B447BB1-417A-4DF0-9810-056C7CB48803Q37791260-8075A260-7C70-41C6-8B7E-0021B44CF8C1Q37850717-8E4763D0-5F34-4199-AB57-E33D3AB4CFCBQ37987526-D0856F49-424C-4339-8BAB-A8CE5A6A07B3Q38081171-F13FF2AF-9D99-45BD-AEE9-C3DEAB2BFF12Q38172801-E8E8BD18-F203-4328-A79D-C5D7D6BF7E69Q38174792-637A9B1C-9BC4-49CD-AEFE-C5444BF2A831Q38542147-450091B7-7311-4137-B317-DE3FA44A4F9BQ38900405-89584F65-6C5A-4160-95BB-550BEE7C0691Q39391390-D443FAF7-8174-44D1-85AC-6F556ADA4AFDQ41416579-10808B0C-3A70-4175-A8D0-7267F9D9EE39Q46974371-06D40B31-E654-49CC-819C-283E9CA9B2CFQ47160095-CA8D9753-558F-4720-87F1-A43477ECAC83Q47596967-D53A67F8-824D-41F0-BB1A-379A41F2B68FQ47758483-C79F9354-2B0B-4F43-A845-1108F610D66EQ48130689-A60A8D6E-CB41-4635-AAC7-BB5342E2E972Q48231667-A6FD74F4-7E93-4249-978E-993EF4E83857Q49710668-1A554959-FFB7-417B-8F50-3EF3822DE19BQ50967637-235AD3BB-8C47-46F5-ACD9-8825579CDF85Q53587012-C376DF6D-9593-4EB4-BA0A-C400B0632211Q59136978-FD9CE046-BC58-42A1-85FC-21CBFC40C9A4
P2860
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
@ast
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
@en
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
@nl
type
label
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
@ast
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
@en
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
@nl
prefLabel
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
@ast
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
@en
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
@nl
P2093
P2860
P1476
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis
@en
P2093
Akira Sekikawa
Hirokazu Fukui
Johji Imura
Katsumasa Suzuki
Kazuhito Ichikawa
Keiko Shiratori
Shigehiko Fujii
Shigeki Tomita
Takahiro Fujimori
Toyohiko Karibe
P2860
P2888
P304
P356
10.1038/LABINVEST.2009.147
P407
P577
2010-03-01T00:00:00Z
P5875
P6179
1048193680